ONCE-WEEKLY WEIGHT-LOSS INJECTION
Mounjaro Weight Loss Programme in Dubai
Doctor-supervised tirzepatide treatment with specialist bariatric nurse and dietitian support.
Medically Supervised Weight Management with Specialist Support
If you are exploring Mounjaro weight loss Dubai treatment options, medically supervised programmes can help you achieve safe and sustainable results under professional care.
Mounjaro® is a once-weekly prescription injection containing tirzepatide. When prescribed as part of a structured medical pathway, tirzepatide can help eligible patients manage appetite, reduce food intake and achieve meaningful weight reduction over time.
At Allure Weightloss, medication is only one part of the programme. Your pathway begins with a doctor’s assessment and can include regular bariatric nurse monitoring, symptom support, progress reviews and dietitian-led guidance.
How Does Mounjaro Help With Weight Loss?
Mounjaro® contains tirzepatide, a medication that acts on two naturally occurring hormone pathways involved in appetite and metabolic regulation: GIP and GLP-1.
By working with these pathways, treatment may help
- Reduce hunger and persistent cravings
- Increase fullness after eating
- Support smaller, more controlled portions
- Improve adherence to dietary change
- Support sustained weight reduction when combined with appropriate lifestyle support
Mounjaro® is prescription-only and must not be used without medical assessment and ongoing clinical oversight
Am I Suitable for Mounjaro Weight Loss Dubai Treatment?
Treatment may be considered for adults who meet relevant clinical criteria, commonly including:
- A BMI of 30 or above; or
- A BMI of 27 or above with one or more weight-related health conditions
Your doctor will also review your medical and family history, current medication, previous weight-loss treatment and any factors that may make tirzepatide unsuitable
Meeting a BMI threshold does not guarantee a prescription. The final decision always rests with the prescribing doctor.
How Mounjaro Treatment Works
Mounjaro® is injected under the skin once each week. Treatment normally begins at a low starting dose so the body can adjust.
The dose may later be increased in stages, but escalation is not automatic. Your doctor will consider your progress, side effects, appetite response and wider clinical needs before changing or maintaining a dose. Some patients may remain at a lower dose for longer, and not every patient requires the maximum available dose.
Your clinical team will explain how to use the pen, when to take your weekly dose, how to store it and what to do if a dose is missed.
What Results Can I Expect?
Clinical studies of tirzepatide have demonstrated substantial average weight reduction in eligible adults when treatment is combined with dietary change and physical activity – upto 22% of your current body weight.
However, no individual result can be guaranteed. Your progress will depend on factors including starting weight, dose, treatment duration, tolerability, adherence, nutrition, activity, sleep and medical history.
Allure focuses on clinically meaningful progress and longer-term weight management—not rapid or unrealistic promises.
Medically Supervised Weight Loss at Allure
Unlike non-medical providers, Allure Weightloss delivers treatment through a comprehensive medical pathway focused on safety and long-term results. Your personalised programme may include:
- Doctor consultation and medical assessment
- Prescription where clinically appropriate
- Dedicated dietitian counselling sessions
- Bariatric specialist nurse monitoring
- Progress tracking and treatment adjustments
This structured approach supports safe, sustainable weight reduction under professional supervision.
Your Mounjaro® Programme at Allure
Unlike pharmacy-only access, our Dubai programmes provide the tiers below to ensure treatment, at the minimum, is used safetly and effectively :
Mounjaro® Core
Essential Medical Pathway
- Initial Obesity Dr Consultation
- Clinical Suitability and Safety Assessment
- Mounjaro® pen Supplied as Prescribed
- Treatment Initiation Guidance
- Monthly Flexibility
Mounjaro® Support
Ongoing Clinical Monitoring
- Initial Obesity Doctor Consultation
- Clinical Suitability and Safety Assessment
- Mounjaro® pen supplied as Prescribed
- Monthly Treatment Monitoring
- Dose Optimisation
- Progress and Symptom Monitoring
- Unlimited WhatsApp Clinical Support
Mounjaro® Premium
Complete Multidisciplinary Support
- Initial Obesity Doctor Consultation
- Clinical Suitability and Safety Assessment
- Mounjaro Medication Pen
- Monthly Bariatric Nurse Review
- Monthly Dietitian Sessions
- Ongoing Nurse Sypmtom Management
- Full Structured Pathway
- Closer Clinical Monitoring
Why Choose Allure Weightloss?
More Than Medication Supply
Our supported programmes are designed for patients who want more than pharmacy-only access. We combine prescribing with the monitoring, education and support needed to use treatment responsibly.
Specialist Weight-Management Team
Your pathway can include a UAE-licensed doctor, bariatric nurse and dietitian, each contributing to a different part of safe and sustainable weight management.
Dose Decisions Based on You
We do not promote automatic escalation to the highest dose. Treatment is reviewed according to your response, progress, side effects and clinical needs.
Complete Treatment Journey
Allure coordinates your care from your initial enquiry through treatment and longer-term planning.
Important Safety Information
Mounjaro® can cause side effects. Commonly reported effects include nausea, diarrhoea, reduced appetite, vomiting, constipation, indigestion and abdominal discomfort. Side effects may be more noticeable when treatment begins or when a dose changes.
Tirzepatide may not be suitable for people with certain medical or family histories, during pregnancy, or alongside some other medication. Serious complications can occur. Your doctor must review your history and current medicines before prescribing.
Do not combine Mounjaro® with another GLP-1-based treatment unless specifically directed by your treating doctor. Contact your clinical team if symptoms are severe, persistent or concerning, and seek urgent medical help where appropriate.
Would You Prefer a Different Treatment Format?
Mounjaro® is not the only prescription weight-management option in Dubai. Suitable patients may also consider once-weekly Wegovy® injection or the once-daily Wegovy® pill following medical assessment.
Begin Your Mounjaro® Assessment
If you are considering Mounjaro treatment in Dubai and the rest of the UAE, the first step is a structured clinical assessment.
Our team can advise whether Mounjaro weight loss Dubai treatment is suitable for your medical profile.
Mounjaro FAQs
Yes. Mounjaro® is injected under the skin once each week. Your clinical team will explain how to administer and store the pen correctly.
Tirzepatide acts on GIP and GLP-1 pathways involved in appetite and metabolic regulation. It may reduce hunger, increase fullness and make controlled eating easier to maintain.
Not necessarily. Treatment begins at a low dose and may be increased gradually, but every dose decision should be made by your prescribing doctor. Tolerability and response are more important than reaching the highest dose.
Weight reduction usually develops progressively rather than immediately. Results vary considerably and depend on dose, treatment duration, adherence, lifestyle and individual biology.
Common side effects include:
Nausea
Vomiting
Diarrhea
Constipation
Loss of appetite
Fatigue
Although rare, serious side effects may include:
Pancreatitis
Severe gastrointestinal issues
Hypoglycemia (especially when used with insulin or sulfonylureas)
Allergic reactions
Thyroid tumors (based on animal studies; human risk is unclear)
Yes, many users experience significant weight loss due to its appetite-suppressing effects and slower digestion. However, Mounjaro in Dubai is currently FDA-approved for type 2 diabetes, though clinical trials are evaluating its use for weight management.
Mounjaro can be combined with other diabetes medications, but caution is required, particularly with insulin or sulfonylureas, as they may increase the risk of low blood sugar (hypoglycemia).
Potential interactions include:
Insulin and sulfonylureas (higher risk of hypoglycemia)
Oral medications (delayed absorption due to slowed digestion)
Other GLP-1 receptor agonists (concurrent use not recommended)
Mounjaro is not recommended for:
Individuals with a personal or family history of medullary thyroid carcinoma (MTC)
Those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Individuals with a history of severe pancreatitis
Pregnant or breastfeeding women (unless advised by a doctor)
The cost of Mounjaro varies depending on individual circumstances and package tiers.
Alcohol should be consumed in moderation, as it may affect blood sugar levels and increase gastrointestinal side effects.
Support depends on your chosen programme. It can include doctor assessment, prescribed medication, monthly bariatric nurse reviews, symptom support, progress monitoring and dietitian consultations.